Desalitech, Ltd., a provider of advanced water treatment solutions and technology, announced today that it has secured an equity investment led by Liberation Capital, LLC. The total investment round of $6.25M will be used for expanding Desalitech's business and working capital. Liberation will also be supporting Desalitech with considerable project finance capital.

Desalitech is commercializing next-generation Reverse Osmosis (RO) water treatment solutions. Its proprietary Closed Circuit Desalination (CCD™) technology reduces cost by 20% or more. This is achieved by reducing energy consumption, reducing capital costs, improving process reliability and flexibility, and greatly reducing the emission of brine waste by raising recovery. The CCD process is uniquely capable of achieving high recoveries, even in problematic water sources, and this can change the economics of a water treatment project dramatically. These proven advantages make Desalitech's solutions superior alternatives for industrial and municipal water treatment and wastewater reuse applications, and for brackish and sea water desalination.

Desalitech has productized CCD technology as packaged-plant solutions for industrial and municipal water supply and wastewater treatment applications. Plants are available as capital equipment sales or as outsourced water treatment solutions. Comprised of industry-standard reverse osmosis membranes and equipment, the technology can be readily retrofitted into existing RO facilities. Desalitech also partners with leading suppliers of water treatment systems to deploy its CCD solutions.

"Ever-increasing water stress, rising costs and increased discharge restrictions are some of the industry's most difficult and important challenges. Solving these problems is what Desalitech is all about," said Nadav Efraty, Desalitech CEO. "Liberation Capital is providing the growth capital we need for product commercialization as well as the project finance that will allow us to create a service-oriented business model. As importantly, the deep industry domain knowledge brought by the Liberation team and their experience in growing global businesses will help us focus our strategy and scale our business as we grow."

"I've known the Desalitech team for several years," said Jeff Garwood, Managing Director of Liberation. "Over this period, the technology has been validated, the management team has grown and matured, and most importantly, the market leaders in the industry have come to understand the technology's benefit and significance."

Rick Stover, Desalitech's Executive Vice President, said, "Next-generation CCD technology is a performance breakthrough for RO water treatment. Desalitech is now prepared to recruit top performers and become a major provider of high-recovery and water reuse solutions in North America and around the world."

Desalitech was founded by Professor Avi Efraty who is the inventor of CCD technology, and has grown under the business leadership of Nadav Efraty. In 2008, the company was funded with $3 million of venture capital investment by AquAgro Fund. Over 75 patents have been granted on the technology, and commercial CCD installations have run continuously for over three years.

About the Companies:

Desalitech provides resource and cost efficient water production and treatment technologies. Its next-generation CCD™ process is a patented, proven, highly flexible and reliable water treatment platform that raises recovery, reduces energy consumption and reduces capital cost, thereby lowering the cost of treating wastewater, industrial water, brackish water and seawater.

Liberation Capital is a Global Private Equity Fund specializing in project finance for distributed renewable energy, water and wastewater projects. Liberation Capital supports modular, repeatable, decentralized projects like those served by Desalitech. Its investment model centers on strategic partnerships with CleanTech technology firms and project developers with multi-project/multi-year investment horizons.